Patent · US Active

Delivery of therapeutic agents by a collagen binding protein

US9526765B2 · kind B2 · utility

8Cited by

4References

12Claims

0Family size

Assignees

The Kitasato Institute · JP
Montefiore Medical Center · US
THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS · US

Inventors

Tulasi Ponnapakkam · New York, US
Sagaya Theresa Leena Philominathan · Cheshire, US
Joshua Sakon · Fayetteville, US
Ranjitha Katikaneni · New York, US
Takaki Koide · Tokyo, JP
Osamu Matsushita · Yokohama, JP
Robert C. Gensure · Luling, US

Key dates

Filing date	Feb 11, 2013
Grant date	Dec 27, 2016
Priority date	—
Expiry date	Feb 11, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y304/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods of delivering therapeutic agents by administering compositions including a bacterial collagen-binding polypeptide segment linked to the therapeutic agent to subjects in need of treatment with the therapeutic agent are provided. Methods of treating hyperparathyroidism, and hair loss using compositions comprising a collagen binding polypeptide and a PTH/PTHrP receptor agonist are provided. In addition, methods of reducing hair regrowth by administering a composition including a collagen binding polypeptide and a PTH/PTHrP receptor antagonist are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.